High-Dose Vitamin C and Kidney Stone Risk

Most adults get enough vitamin C from food, and supplementing within recommended ranges is considered safe for healthy people. At very high doses, however, vitamin C metabolism produces oxalate, a compound linked to the most common type of kidney stone, which makes dose awareness important for certain individuals.

What Vitamin C Does in the Body

According to the NIH Office of Dietary Supplements (ODS), vitamin C is required for the biosynthesis of collagen, an essential component of connective tissue that plays a vital role in wound healing. It is also needed to make L-carnitine and certain neurotransmitters, and it is involved in protein metabolism. Beyond these structural roles, vitamin C acts as an important physiological antioxidant that limits damage from free radicals and helps regenerate other antioxidants, including alpha-tocopherol (vitamin E).

The ODS also notes, with strong evidence, that vitamin C supports immune function and enhances the absorption of nonheme, or plant-based, iron. These are well-established physiological functions, not disease claims. As required by law, supplements are not intended to diagnose, treat, cure or prevent any disease and these statements have not been evaluated by the FDA.

How Much Vitamin C Do Adults Need?

The NIH ODS reports the following Dietary Reference Intake targets for adults aged 19 and older:

• Men: 90 mg per day
• Women: 75 mg per day
• Tolerable Upper Intake Level (UL) for adults: 2,000 mg per day

The UL represents the highest daily intake likely to pose no risk of adverse effects for healthy people. Lower upper limits apply to children and adolescents. The ODS notes that intakes above the UL raise the risk of gastrointestinal effects such as diarrhea and cramps. Importantly, the UL does not apply to people receiving vitamin C for medical treatment, who should be under a physician's care.

The Connection Between Vitamin C and Kidney Stones

The kidney stone concern centers on how the body breaks down vitamin C. A portion of absorbed ascorbic acid is converted to oxalate and excreted in the urine. When urinary oxalate concentration rises, the risk of calcium oxalate crystal formation increases. Calcium oxalate stones account for the majority of kidney stones diagnosed in clinical practice.

At intakes near the recommended daily amounts, the amount of oxalate produced is modest and not considered a concern for most healthy adults. The risk becomes more relevant at doses substantially above the 2,000 mg UL, particularly with long-term use. People who already have a history of kidney stones, kidney disease, or a condition called hyperoxaluria, which involves abnormally high oxalate in the urine, face a meaningfully higher risk at elevated doses.

What the Evidence Grades Tell Us

The NIH ODS uses evidence grading to communicate how confident researchers are in various claims. Here is how vitamin C's most discussed benefits stack up:

• Strong evidence: Vitamin C is required for biosynthesis of collagen, L-carnitine, and certain neurotransmitters, and acts as a physiological antioxidant.
• Strong evidence: Vitamin C supports immune function and enhances absorption of nonheme iron.
• Moderate evidence: Regular vitamin C supplementation modestly shortens the duration of the common cold.
• Insufficient evidence: Taking vitamin C prophylactically prevents the common cold in the general population.
• Insufficient evidence: Vitamin C supplements reduce the risk of cancer.
• Insufficient evidence: Vitamin C supplements prevent cardiovascular disease.
• Limited evidence: Vitamin C reduces the risk of age-related cataract or macular degeneration.

This grading matters because many people take very high doses of vitamin C hoping to prevent serious diseases, yet the ODS rates that evidence as insufficient. Taking on additional kidney stone risk for a benefit that has not been established is a tradeoff worth discussing with a clinician.

Drug Interactions to Know

The ODS identifies two notable interaction areas that anyone taking medications should be aware of before adding high-dose vitamin C.

Chemotherapy and Radiation Therapy

It is uncertain whether high-dose vitamin C and other antioxidants protect tumor cells, protect normal tissue, or alter treatment effectiveness. Anyone undergoing chemotherapy or radiation should consult their oncologist before taking vitamin C or other antioxidant supplements, especially in high doses.

Statin and Niacin Therapy

Vitamin C, in combination with other antioxidants, may attenuate the rise in HDL cholesterol produced by combination niacin plus simvastatin therapy. It is not known whether this effect occurs with other lipid-altering regimens. Clinicians should monitor lipid levels in people taking both statins and antioxidant supplements. If you are on any lipid medication, talk to your doctor or pharmacist before adding a vitamin C supplement.

Who Should Be Most Cautious

Certain groups face a higher risk from elevated vitamin C intake and should be especially careful about doses above the 2,000 mg UL:

• People with a personal or family history of kidney stones, particularly calcium oxalate stones
• People with chronic kidney disease or reduced kidney function
• People with hereditary conditions that affect oxalate metabolism
• People taking chemotherapy, radiation therapy, or statin-based lipid medications

If you fall into any of these categories, consult a clinician before using high-dose vitamin C supplements. Even if you do not, personal dosing decisions should involve a healthcare provider or pharmacist who knows your full health picture.

Practical Takeaways

For most healthy adults, getting vitamin C through a varied diet that includes fruits and vegetables, or supplementing at or below the 90 mg to 75 mg daily targets, carries no meaningful kidney stone risk. The 2,000 mg per day UL set by the NIH ODS is the threshold above which adverse effects, including elevated urinary oxalate, become a real concern. Doses well above that level are sometimes marketed for immune or antioxidant benefits, but the evidence supporting those specific claims ranges from moderate to insufficient. The physiological roles of vitamin C are well established and important. The case for megadosing to prevent disease is not. If you are considering a high-dose supplement, bring the label to your next appointment and review it with your doctor or pharmacist before starting.

Sources

• NIH Office of Dietary Supplements, Vitamin C Fact Sheet for Health Professionals: https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/
• NIH Office of Dietary Supplements, Vitamin C Fact Sheet for Consumers: https://ods.od.nih.gov/factsheets/VitaminC-Consumer/
• National Academies of Sciences, Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids: https://nap.nationalacademies.org/catalog/9810/dietary-reference-intakes-for-vitamin-c-vitamin-e-selenium-and-carotenoids